Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Prospective Longitudinal Study of Cladribine Tablets (CLADB Study) Demonstrates Sustained Reduction in Kappa Free Light Chains in Relapsing Multiple Sclerosis (RRMS) at 96 Weeks

              Author:Ammoscato, Francesca   Skonieczna, Justyna   Bestwick, Jonathan   Holden, David   Aboulwafa, Mohammad   Andrews, Michael   Turner, Benjamin   Marta, Monica   Schmierer, Klaus   Baker, David   Giovannoni, Gavin   Gnanapavan, Sharmilee   

              Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

              Topic:Multiple Sclerosis  

              Program Number:P10.008  

              Author Institution:Blizard Institute, Queen Mary University of London, London, United Kingdom  Wolfson Institute, Queen Mary University of London, London, United Kingdom  Barts Health NHS Trust, London, United Kingdom